| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.JTBI.2019.02.020 |
| P932 | PMC publication ID | 6447051 |
| P698 | PubMed publication ID | 30851550 |
| P894 | zbMATH Open document ID | 1411.92179 |
| P2093 | author name string | Denise E Kirschner | |
| Marissa Renardy | |||
| P2860 | cites work | Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis | Q24537176 |
| Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project | Q28145755 | ||
| Recent Transmission of Tuberculosis - United States, 2011-2014 | Q28604185 | ||
| Social contacts and mixing patterns relevant to the spread of infectious diseases | Q28755323 | ||
| The growing burden of tuberculosis: global trends and interactions with the HIV epidemic | Q29616520 | ||
| The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling | Q30244104 | ||
| Using data on social contacts to estimate age-specific transmission parameters for respiratory-spread infectious agents. | Q30356829 | ||
| Mixing in age-structured population models of infectious diseases | Q30408725 | ||
| Using time-use data to parameterize models for the spread of close-contact infectious diseases | Q33370506 | ||
| Potential impact of tuberculosis vaccines as epidemic control agents | Q33956317 | ||
| Variation in protection by BCG: implications of and for heterologous immunity | Q34288541 | ||
| Impact and cost-effectiveness of new tuberculosis vaccines in low- and middle-income countries | Q34441930 | ||
| Safety and immunogenicity of the recombinant BCG vaccine VPM1002 in a phase 1 open-label randomized clinical trial | Q34660987 | ||
| A defined tuberculosis vaccine candidate boosts BCG and protects against multidrug-resistant Mycobacterium tuberculosis | Q35033838 | ||
| Potential public health impact of new tuberculosis vaccines | Q35872932 | ||
| The success and failure of BCG - implications for a novel tuberculosis vaccine | Q36191944 | ||
| Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics | Q37288026 | ||
| Systematic review of mathematical models exploring the epidemiological impact of future TB vaccines | Q37473293 | ||
| Modeling socio-demography to capture tuberculosis transmission dynamics in a low burden setting | Q38940389 | ||
| Novel approaches to tuberculosis vaccine development | Q38999845 | ||
| The natural history of tuberculosis: the implications of age-dependent risks of disease and the role of reinfection | Q39566509 | ||
| The Prevalence of Latent Tuberculosis Infection in the United States | Q40005296 | ||
| Projecting social contact matrices in 152 countries using contact surveys and demographic data. | Q40045625 | ||
| Practical aspects of backward bifurcation in a mathematical model for tuberculosis | Q40401794 | ||
| First-in-human trial of the post-exposure tuberculosis vaccine H56:IC31 in Mycobacterium tuberculosis infected and non-infected healthy adults | Q41148040 | ||
| Safety and immunogenicity of candidate vaccine M72/AS01E in adolescents in a TB endemic setting | Q41162993 | ||
| Estimated rate of reactivation of latent tuberculosis infection in the United States, overall and by population subgroup. | Q41291128 | ||
| A novel liposomal adjuvant system, CAF01, promotes long-lived Mycobacterium tuberculosis-specific T-cell responses in human | Q41630579 | ||
| Tuberculous meningitis and miliary tuberculosis in young children. | Q44811876 | ||
| Global stability of an age-structure model for TB and its applications to optimal vaccination strategies | Q45046802 | ||
| Ag85B-ESAT-6 adjuvanted with IC31 promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in naïve human volunteers | Q45233558 | ||
| Modelling the effects of pre-exposure and post-exposure vaccines in tuberculosis control | Q46471225 | ||
| Tuberculosis vaccines: Opportunities and challenges | Q47552546 | ||
| Trade-off between BCG vaccination and the ability to detect and treat latent tuberculosis. | Q51795293 | ||
| Prevalence of latent tuberculous infection among adults in the general population of Ca Mau, Viet Nam. | Q54268169 | ||
| A multistage tuberculosis vaccine that confers efficient protection before and after exposure. | Q54391413 | ||
| Phase 2b Controlled Trial of M72/AS01 Vaccine to Prevent Tuberculosis | Q57069957 | ||
| What is the outcome of targeted tuberculosis screening based on universal genotyping and location? | Q83854592 | ||
| P921 | main subject | tuberculosis | Q12204 |
| P6104 | maintained by WikiProject | WikiProject Mathematics | Q8487137 |
| P1104 | number of pages | 11 | |
| P304 | page(s) | 1-11 | |
| P577 | publication date | 2019-03-06 | |
| P1433 | published in | Journal of Theoretical Biology | Q2153724 |
| P1476 | title | Evaluating vaccination strategies for tuberculosis in endemic and non-endemic settings | |
| P478 | volume | 469 |
| Q96340995 | A Framework for Network-Based Epidemiological Modeling of Tuberculosis Dynamics Using Synthetic Datasets |
| Q99574023 | A structured Markov chain model to investigate the effects of pre-exposure vaccines in tuberculosis control |
| Q89820519 | Clinical Development of New TB Vaccines: Recent Advances and Next Steps |
| Q99631188 | Global sensitivity analysis of biological multi-scale models |
| Q101135862 | New tuberculosis vaccines: advances in clinical development and modelling |
| Q100490406 | Potential impact of tuberculosis vaccines in China, South Africa, and India |
| Q111441931 | Structural identifiability analysis of age-structured PDE epidemic models |
Search more.